Cohn Labs Inc.is a biotechnology company, focused on discovery and synthesis of small molecules which have a profound effect on the central nervous system. Our aim is to treat mental health conditions such as addiction related to substance abuse, depression, end stage anxiety and various psychiatric ailments. License applications have been submitted and R&D has been started.